Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gynaecological Cancers Congress 2024

ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options

The promise of antibody drug conjugates (ADCs) in ovarian cancer: Mechanisms of action and emerging therapeutics

Date

22 Jun 2024

Session

ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options

Topics

Tumour Site

Ovarian Cancer

Presenters

Toon Van Gorp

Authors

T. Van Gorp

Author affiliations

  • University Hospitals Leuven - Campus Gasthuisberg, Leuven/BE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A, discussion and concluding remarks

Presenter: Nicoletta Colombo

Session: ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.